A feasibility study to collect data in patients with haemophilia
Study identifier:D0960M00006
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A multi centre study with no treatment, designed to gain information about the haemophilia patient population
Medical condition
Hemophilia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Male
Actual Enrollment
50
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Dec 2008
Primary Completion Date: -
Study Completion Date: 01 Jun 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Other: 1 Laboratory variables | Other: Laboratory variables 1 visit |
Contacts
Investigators
Principal Investigator
Erik Berntorp
Malmo University
